Clinical research

A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients

EuroIntervention 2012;7:1051-1059. DOI: 10.4244/EIJV7I9A167

Ran Kornowski
Ran Kornowski1,2*, MD, FESC, FACC; Hana Vaknin-Assa1,2, MD; Abid Assali1,2, MD; Eli I. Lev1,2, MD; Avital Porter1,2, MD; Alexander Battler1,2, MD; Tamir Bental1,2, MD
1. Cardiology Department, Rabin Medical Center (Beilinson and Golda Hasharon Hospitals), Petah Tikva, Israel; 2. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Aims: To conduct a risk-adjusted gender-based analysis of clinical outcomes following drug-eluting stent (DES) versus bare metal stent (BMS) implantation in patients with

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary artery diseaseclinical researchbare metal stent
Read next article
Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

Latest news